Once-weekly semaglutide 7ยท2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial - PubMed

For the Bulgarian, Hungarian and Polish translations of the abstract see Supplementary Materials section.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov